Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by Professor Tom Foltynie (Ïã¸ÛÁùºÏ²Ê Queen Square Institute of Neurology) and Professor Li Wei (Ïã¸ÛÁùºÏ²Ê School of Pharmacy).
, ,ÌýÏã¸ÛÁùºÏ²Ê News